These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 3077710)
1. [Use of immunoenzyme analysis for detecting secretory and serum antibodies in those vaccinated with live influenza vaccine]. Kozhukhov VM; Orlov VA; Zhilova GP; Malikova EV Tr Inst Im Pastera; 1988; 64():120-6. PubMed ID: 3077710 [No Abstract] [Full Text] [Related]
2. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine. Unanov SS; Yuminova NV; Akopova II Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541 [TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of the ELISA immunoenzyme test for detecting the antibody response of persons vaccinated with an inactivated influenza vaccine]. Proietti E; Rapicetta M; Morace G; Arangio-Ruiz G; Macchia T; Mancini G Ann Ist Super Sanita; 1982; 18(3):521-4. PubMed ID: 7187838 [No Abstract] [Full Text] [Related]
4. [Use of the elution inhibition reaction for detecting antineuraminidase antibodies in the sera of persons inoculated with inactivated influenza vaccine]. Briantseva EA Tr Inst Im Pastera; 1982; 59():59-62. PubMed ID: 6764988 [No Abstract] [Full Text] [Related]
5. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981 [TBL] [Abstract][Full Text] [Related]
6. Characteristic of humoral response of elderly to inactivated influenza vaccine. Siennicka J Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157 [TBL] [Abstract][Full Text] [Related]
7. Difficulties in standardizing the neuraminidase content of influenza vaccines. Gérentes L; Kessler N; Aymard M Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973 [TBL] [Abstract][Full Text] [Related]
8. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
9. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715 [TBL] [Abstract][Full Text] [Related]
10. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry. Worrall EE; Sudarisman ; Priadi A Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183 [TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity and safety of domestic slit influenza vaccine]. Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057 [No Abstract] [Full Text] [Related]
12. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677 [TBL] [Abstract][Full Text] [Related]
13. [Influenza epidemic in a nursing home caused by a virus not included in the vaccine]. Beyer WE; Bakker G; van Beek R; Masurel N Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1973-7. PubMed ID: 8413706 [TBL] [Abstract][Full Text] [Related]
14. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus. Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928 [TBL] [Abstract][Full Text] [Related]
15. Anti-neuraminidase antibody response after administration of a split influenza vaccine. Constantinescu C; Ioniţă E; Alexandrescu V; Maţepiuc M; Creţescu L; Niculescu IT Arch Roum Pathol Exp Microbiol; 1985; 44(1):37-41. PubMed ID: 4038049 [No Abstract] [Full Text] [Related]
16. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Cox RJ; Madhun AS; Hauge S; Sjursen H; Major D; Kuhne M; Höschler K; Saville M; Vogel FR; Barclay W; Donatelli I; Zambon M; Wood J; Haaheim LR Vaccine; 2009 Mar; 27(13):1889-97. PubMed ID: 19368768 [TBL] [Abstract][Full Text] [Related]
17. Epidermal DNA vaccine for influenza is immunogenic in humans. Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518 [TBL] [Abstract][Full Text] [Related]
18. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine. Del Giudice G; Hilbert AK; Bugarini R; Minutello A; Popova O; Toneatto D; Schoendorf I; Borkowski A; Rappuoli R; Podda A Vaccine; 2006 Apr; 24(16):3063-5. PubMed ID: 16464520 [TBL] [Abstract][Full Text] [Related]
19. The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines. Potter CW; Jennings R; Clark A Dev Biol Stand; 1977 Jun 1-3; 39():323-8. PubMed ID: 604115 [No Abstract] [Full Text] [Related]
20. [Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines]. Naĭkhin AN; Topuriia NV; Denisov GM Mikrobiol Zh (1978); 1980; 42(5):642-5. PubMed ID: 7432210 [No Abstract] [Full Text] [Related] [Next] [New Search]